Bone density in survivors of childhood cancer.
Advances in combination chemotherapy, radiation therapy, surgery, and bone marrow transplantation have resulted in markedly improved survival rates for many children with cancer. Advancements in therapy, however, have led to new concerns, namely long-term consequences of effective treatments. Young adult and adult survivors of childhood cancer are at risk for a number of disorders related to therapy. Specifically, the young adult who has survived cancer, attendant treatments, and their complications is at risk for factors that can lead to suboptimal acquisition of peak bone mass. These factors include chronic illness, nutritional deficiencies, limited physical activity, and treatment with glucocorticoids, multiagent chemotherapy, and radiation. The long-term adverse effects of these therapies on endocrine systems, especially sex steroid and growth hormone deficiencies, are additional risk factors for some patients. After a brief review of the processes associated with acquisition of peak bone mass in the young adult, this article examines the impact of cancer and cancer therapy on bone mineral density in survivors of childhood cancer.
Mulder
Jean E
JE
Department of Medicine, College of Physicians and Surgeons, New York, NY, USA. JMULDER@partners.org
Bilezikian
John P
JP
D000293:Adolescent; D000328:Adult; D015519:Bone Density / Q000502:physiology*; D001846:Bone Development / Q000502:physiology; D001842:Bone and Bones / Q000473:pathology / Q000503:physiopathology; D002648:Child; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology* / Q000628:therapy; D012307:Risk Factors; D017741:Survivors